Free Trial

Vertex Pharmaceuticals (VRTX) Stock Chart & Stock Price History

Vertex Pharmaceuticals logo
$485.22 -21.78 (-4.30%)
Closing price 04:00 PM Eastern
Extended Trading
$485.28 +0.05 (+0.01%)
As of 04:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Vertex Pharmaceuticals Stock Price Performance

The Vertex Pharmaceuticals (VRTX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 19.10%, with a year-to-date return of 7.02%. In the past month, the stock has decreased 5.87%, reflecting recent market activity.

As of the latest close, Vertex Pharmaceuticals traded at $507.00 with a market cap of $128.68 billion and volume of 952,687 shares. Five years ago, the stock traded at $181.34, representing a 167.55% increase over that period. At the time, it had a market cap of $47.04 billion and a volume of 1.09 million shares.

Receive VRTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vertex Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
5 Day
Performance
-3.59%
1 Month
Performance
-5.87%
3 Month
Performance
+1.03%
Year-To-Date
Performance
+7.02%
1 Year
Performance
+19.10%
5 Year
Performance
+167.55%

VRTX Stock Chart for Tuesday, October, 13, 2026

Vertex Pharmaceuticals Stock Price History

Price Date
0 Results
DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
10/12/2026$510.08$507.00
-0.60%
$514.80$506.00952,687 shs$128.68 billion
10/09/2026$503.25$510.08
+1.36%
$514.90$502.061.48 million shs$129.46 billion
10/08/2026$505.64$503.25
-0.47%
$507.87$498.901.49 million shs$127.72 billion
10/07/2026$502.31$505.64
+0.66%
$511.51$503.94806,633 shs$128.33 billion
10/06/2026$503.50$502.31
-0.24%
$507.41$496.33775,003 shs$127.49 billion
10/05/2026$504.73$503.50
-0.24%
$506.01$496.15914,817 shs$127.79 billion
10/02/2026$506.74$504.73
-0.40%
$509.50$499.95939,520 shs$128.10 billion
10/01/2026$522.81$506.74
-3.07%
$523.52$505.271.16 million shs$128.61 billion
09/30/2026$526.73$522.81
-0.74%
$529.72$522.741.14 million shs$132.69 billion
09/29/2026$527.67$526.73
-0.18%
$529.46$519.25672,665 shs$133.68 billion
09/28/2026$526.19$527.67
+0.28%
$529.89$521.16817,153 shs$133.92 billion
09/25/2026$522.38$526.19
+0.73%
$527.69$518.92754,282 shs$133.55 billion
09/24/2026$516.34$522.38
+1.17%
$528.99$515.30936,619 shs$132.58 billion
09/23/2026$514.99$516.34
+0.26%
$525.43$509.561.21 million shs$131.05 billion
09/22/2026$510.72$514.99
+0.84%
$525.97$508.141.38 million shs$130.70 billion
09/21/2026$508.34$510.72
+0.47%
$514.10$501.01905,500 shs$129.62 billion
09/18/2026$516.34$508.34
-1.55%
$518.10$505.012.43 million shs$129.02 billion
09/17/2026$513.26$516.34
+0.60%
$519.07$510.20899,601 shs$131.05 billion
09/16/2026$514.63$513.26
-0.27%
$517.95$511.35638,064 shs$130.27 billion
09/15/2026$519.51$514.63
-0.94%
$519.94$511.00824,740 shs$130.62 billion
09/14/2026$515.44$519.51
+0.79%
$525.29$514.66824,718 shs$131.85 billion

This page (NASDAQ:VRTX) was last updated on 10/13/2026 by MarketBeat.com Staff.
From Our Partners